Santiago
Psychedelic
Research
Symposium

Over the last two decades, there has been a resurgence of interest in the scientific study of psychedelic drugs, in particular the so-called ‘classical psychedelics’, whose structure resembles serotonin, a molecule found in the brains and bodies of many animals, including humans. The field of psychedelic research is remarkably multidisciplinary, attracting interest across basic science, applied science, and clinical science. Research contributions from fields like neuroscience, psycho-pharmacology, psychology, psychiatry, molecular biology, biochemistry, law, public policy, computational modelling, and artificial intelligence have increased our fundamental understanding in a range of areas: At the most basic level, biochemists and neuroscientists have made progress understanding the mechanisms by which these compounds achieve their physiological effects. Clinically, psychologists and psychiatrists have shown that psychedelic compounds can be used to treat disorders like anxiety, depression, post-traumatic stress disorder, and end-of-life-distress. Computationally, scientists are using psychedelic research insights to develop better models of brain connectivity and conscious experience.

The Santiago Psychedelic Research Symposium brings together experts to discuss the state-of-the-art in psychedelic research science. Each of our speakers has made important research contributions advancing distinct domains of psychedelic science over the last several years, spanning public policy and health, clinical psychology, neuroscience, and brain imaging.

Detailed abstracts and Bios for each of our speakers are available here.

Program

20 May, 16:00 - 19.00